This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of British Columbia directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $25,000
SONRIS 2.0: Sepsis Outcomes Network to Improve Survival
CIHR · 2019 · Principal investigator
- $860,625
Semaglutide in comorbid obesity and schizophrenia-spectrum disorders for metformin non-responders: a double-blind randomized control trial
CIHR · 2019 · Co-investigator
SONRIS 2.0: Sepsis Outcomes Network to Improve Survival
Principal investigators: Boyd, John H; Brunham, Liam R; Hux, Janet E; Lovshin, Julie A; Rush, Barret; Russell, James A; Senior, Peter A; Drucker, Daniel J; Kumar, Anand; Walley, Keith R
Keywords: Diabetes; Infectious Disease; Lipoproteins; Nutrition; Sepsis
Semaglutide in comorbid obesity and schizophrenia-spectrum disorders for metformin non-responders: a double-blind randomized control trial
Principal investigators: Hahn, Margaret; Agarwal, Sri Mahavir
Keywords: Antipsychotics; Cognition; Diabetes; Glucagon-Like-Peptide 1 Receptor Agonists; Magnetic Resonance Imaging; Metformin; Obesity; Psychosis; Schizophrenia; Visceral Adiposity
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.